Effectiveness and Safety of Dabigatran Reversal with Idarucizumab in the Taiwanese Population: A Comparison Based on Eligibility for Inclusion in Clinical Trials

Background and Objectives: The effectiveness and safety of idarucizumab for the reversal of the effects of dabigatran have been proven. However, there remains a paucity of literature comprehensively investigating outcomes in real-world patients. This is especially true when comparing patients who we...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Jhih-Wei, Wang, Chien-Ho, Chu, Chan-Lin, Liao, Shu-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224188/
https://www.ncbi.nlm.nih.gov/pubmed/37241113
http://dx.doi.org/10.3390/medicina59050881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224188/
https://www.ncbi.nlm.nih.gov/pubmed/37241113
http://dx.doi.org/10.3390/medicina59050881

Ejemplares similares